<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740542</url>
  </required_header>
  <id_info>
    <org_study_id>PRO18010137</org_study_id>
    <nct_id>NCT03740542</nct_id>
  </id_info>
  <brief_title>Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy</brief_title>
  <official_title>A Phase III Randomized Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is a phase III randomized trial to study the value of the addition of a
      pyloroplasty procedure versus no pyloroplasty procedure during the performance of
      esophagectomy. Pyloroplasty is a type of pyloric drainage procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients selected for enrollment in this study will be adults (18-85 years of age) that have
      been scheduled for exploration, and possible esophagectomy. Prior to surgery, patients will
      be randomized to one of two groups. Group A will have a pyloroplasty performed as part of the
      esophagectomy procedure. Group B will not have a pyloroplasty performed. Postoperative
      patient outcomes will be assessed for 24 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 27, 2018</start_date>
  <completion_date type="Anticipated">January 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pneumonia</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Defined as meeting 3 of 5 characteristics: fever, leukocytosis, chest x-ray (CXR) with infiltrate, positive culture from sputum, or treatment with antibiotics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>esophageal anastomosis leak requiring surgery</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Defined as a leak at the esophageal anastomosis site as evidenced by Barium Swallow Study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death within 30 days of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to start oral diet</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Number of days from surgery to starting oral diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment by completion of SF36 Quality of Life questionnaire</measure>
    <time_frame>Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery</time_frame>
    <description>SF36 Quality of Life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life (HRQL) measured by completion of GERD HRQL questionnaire</measure>
    <time_frame>Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery.</time_frame>
    <description>Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life (HRQL) questionnaire prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysphagia as reported by patient using the Dysphagia scale</measure>
    <time_frame>Prior to esophagectomy, at the first postoperative visit, and 4, 6, and 12 months after surgery.</time_frame>
    <description>Dysphagia scale measures swallowing difficulty on a scale of 1-5. (1=no difficulty swallowing; 2=difficulty swallowing hard solids; 3=difficulty swallowing soft solids; 4=difficulty swallowing liquids; 5=unable to swallow anything. A lower score represents a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasogastric tube drainage measured in milliliters</measure>
    <time_frame>From date of surgery until date nasogastric tube is removed or date of discharge from hospital, whichever came first, assessed up to 24 months.</time_frame>
    <description>Measured in milliliters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Replacement of nasogastric tube reported as number of days from tube removal to reinsertion</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Number of days from nasogastric tube removal to reinsertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Esophageal dilations reported as the number of esophageal dilations performed</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Number of esophageal dilations performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>From date of surgery until the date of discharge from hospital, assessed up to 24 months.</time_frame>
    <description>Number of days in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspiration as reported on radiographic imaging</measure>
    <time_frame>Performed when clinically indicated up to 24 months postoperatively</time_frame>
    <description>Radiographic imaging reports</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastric outlet obstruction as reported on barium swallow reports</measure>
    <time_frame>Performed when clinically indicated up to 24 months postoperatively</time_frame>
    <description>Barium swallow reports</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-admission to hospital</measure>
    <time_frame>Up to 24 months postoperatively</time_frame>
    <description>Number of days from hospital discharge to re-admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unexpected return to the Operating Room</measure>
    <time_frame>Up to 24 months postoperatively</time_frame>
    <description>Procedure performed in the Operating Room</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Esophageal anastomotic leak not requiring surgery</measure>
    <time_frame>Performed when clinically indicated up to 24 months postoperatively</time_frame>
    <description>Barium swallow reports</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory complications other than pneumonia</measure>
    <time_frame>Performed when clinically indicated up to 24 months postoperatively</time_frame>
    <description>Radiographic imaging reports</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Esophagectomy</condition>
  <arm_group>
    <arm_group_label>Esophagectomy with Pyloroplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Esophagectomy with Pyloroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Esophagectomy without Pyloroplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Esophagectomy without Pyloroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Esophagectomy</intervention_name>
    <description>Surgical removal of part of esophagus</description>
    <arm_group_label>Esophagectomy with Pyloroplasty</arm_group_label>
    <arm_group_label>Esophagectomy without Pyloroplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pyloroplasty</intervention_name>
    <description>pyloric drainage procedure</description>
    <arm_group_label>Esophagectomy with Pyloroplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be willing to undergo esophagectomy for benign or malignant condition

          -  Women and men 18-85 years of age

          -  Eastern Cooperative Oncology Group (ECOG) performance status 0-2

          -  Stomach is used as conduit

        Exclusion Criteria:

          -  Previous operations of the pylorus

          -  Previous gastric resection

          -  Patients who are unable to tolerate surgery

          -  Participants may be enrolled and randomized on the study but may be excluded at the
             time of the surgery because of findings by the surgeon that preclude performing
             esophagectomy, or using stomach as a conduit or findings which preclude following the
             randomized arm.

          -  Age &lt;18 years of age or &gt; 85 years of age

          -  BMI &gt; 50
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Luketich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie Ward, BSN</last_name>
    <phone>412-647-8583</phone>
    <email>wardj@upmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Ward, BSN</last_name>
      <phone>412-647-8583</phone>
      <email>wardj@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>James Luketich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neil Christie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Schuchert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arjun Pennathur, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryan Levy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Lamb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajeev Dhupar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Inderpal Sarkaria, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Villa Sanchez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicholas Baker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Omar Awais, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Gooding</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olugbenga Okusanya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 20, 2018</study_first_submitted>
  <study_first_submitted_qc>November 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>October 4, 2019</last_update_submitted>
  <last_update_submitted_qc>October 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>James Luketich</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

